Byrne Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Buy
517
+77
+18% +$78.7K 0.34% 72
2026
Q1
$405K Sell
440
-17
-4% -$17.2K 0.24% 81
2025
Q4
$491K Buy
+457
New +$437K 0.27% 80
2025
Q3
Sell
-401
Closed -$298K 96
2025
Q2
$313K Buy
+401
New +$312K 0.21% 84
2025
Q1
Sell
-434
Closed -$361K 80
2024
Q4
$335K Sell
434
-5
-1% -$4.14K 0.24% 78
2024
Q3
$389K Sell
439
-27
-6% -$24.3K 0.27% 79
2024
Q2
$424K Sell
466
-6
-1% -$4.8K 0.3% 75
2024
Q1
$367K Sell
472
-64
-12% -$45.5K 0.25% 86
2023
Q4
$312K Sell
536
-5
-0.9% -$2.92K 0.24% 89
2023
Q3
$291K Buy
541
+192
+55% +$98.9K 0.24% 85
2023
Q2
$164K Hold
349
0.11% 156
2023
Q1
$120K Buy
349
+19
+6% +$6.41K 0.09% 163
2022
Q4
$121K Sell
330
-10
-3% -$3.55K 0.09% 163
2022
Q3
$110K Buy
340
+169
+99% +$53.5K 0.08% 151
2022
Q2
$55K Sell
171
-64
-27% -$19.2K 0.04% 182
2022
Q1
$67K Buy
235
+10
+4% +$2.57K 0.04% 196
2021
Q4
$62K Buy
+225
New +$57K 0.04% 202

Other funds holding LLY

Byrne Asset Management's LLY Position: Q2 2026 in Review

Byrne Asset Management increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $78.7K and bringing the position to 517 shares worth $620K. The position accounts for 0.34% of the portfolio, ranked #72.

Byrne Asset Management first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Byrne Asset Management held 517 shares of Eli Lilly worth $620K as of Q2 2026.
  • Byrne Asset Management bought 77 Eli Lilly shares in Q2 2026, an estimated $78.7K.
  • Eli Lilly made up 0.34% of Byrne Asset Management's portfolio in Q2 2026, its #72 holding.
  • Byrne Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.